ダウン症候群における認知機能に対する皮膚経由のニコチンの影響
Lancet (London, England)
|October 29, 2000
まとめ
ニコチンは,ダウン症の成人の注意力と情報処理を改善する可能性があります.
科学分野:
- 神経科学と遺伝学について
- 薬理学とセラピュティクス
背景:
- ダウン症候群は,アルツハイマー病と神経病理学的類似性を共有しており,特にコレリン代謝欠乏症があります.
- 現在,ダウン症候群の確固たる治療法は存在しない.
- 認知障害は,ダウン症候群の患者に重大な課題となっています.
研究 の 目的:
- ダウン症候群の成人の認知能力に対するニコチンアゴニスティック刺激の影響を調査する.
- ニコチンパッチの効果とプラセボの効果を比較する
主な方法:
- ダウン症と診断された5人の成人を対象とした小規模な研究.
- 5mgのニコチンパッチの投与とプラセボの投与.
- 注意と情報処理に焦点を当てた認知能力の評価.
主要な成果:
- ニコチン投与を受けたダウン症候群の患者では,注意力および情報処理の予備的な改善が観察されました.
- 観察された認知の変化は,健康な対照被験者と比較された.
- この研究では,認知機能の有望な傾向が指摘された.
結論:
- ニコチン刺激は,ダウン症候群の成人の特定の認知機能を高める可能性を示しています.
- これらの事前調査結果は,より大きなサンプルサイズでさらなる調査を正当化しています.
- 結果は,参加者数が少ないため,まだ一般化できません.
関連する概念動画
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.


